Andaris gets ultrasound contrast patent
Add U.K. firm Andaris to the list of companies with patents on ultrasound contrast technology. The Nottingham firm reported this month that it has received patent No. 5,741,478 from the U.S. Patent and Trademark Office for its microcapsule technology.
Add U.K. firm Andaris to the list of companies with patents on ultrasound contrast technology. The Nottingham firm reported this month that it has received patent No. 5,741,478 from the U.S. Patent and Trademark Office for its microcapsule technology. The patent applies to its Quantison and Myomap ultrasound contrast agents under development, as well as its platelet substitute, Synthocytes, Andaris said.
Seven Takeaways from Meta-Analysis of PSMA Radiotracers for Prostate Cancer Imaging
December 1st 2023In a newly published meta-analysis of 24 studies, researchers noted that the PSMA PET radiotracer 18F PSMA-1007 may provide more benefit than 68Ga Ga-PSMA-11 for primary staging of patients with prostate cancer and detection of local lesion recurrence, but also has drawbacks with higher liver uptake and multiple reports of false positive bone lesions.
Study: Regular Mammography Screening Reduces Breast Cancer Mortality Risk by More than 70 Percent
November 30th 2023Consistent adherence to the five most recent mammography screenings prior to a breast cancer diagnosis reduced breast cancer death risk by 72 percent in comparison to women who did not have the mammography screening, according to new research findings presented at the annual Radiological Society of North America (RSNA) conference.
Chest CT Study Shows Higher Emphysema Risk from Combination of Marijuana and Cigarette Smoking
November 28th 2023People who smoke marijuana and cigarettes have 12 times the risk for centrilobular emphysema than non-smokers, according to new computed tomography (CT) research presented at the annual Radiological Society of North America (RSNA) conference.
